Why the study?
Does perioperative beta-blocker therapy improve outcomes in patients undergoing noncardiac surgery?
Does perioperative beta-blocker therapy improve outcomes in patients undergoing noncardiac surgery?
This paper evaluates the reliability of evidence supporting the use of perioperative beta-blockers in patients undergoing noncardiac surgery.
Questions reliability of perioperative beta-blocker evidence in noncardiac surgery; leaves open optimal use pending larger trials.
Of the approximately 26 million North Americans who undergo noncardiac surgical procedures every year,[1][1],[2][2] 1%–5% suffer a major perioperative cardiovascular event.[1][1],[3][3] Perioperative ischemic events prolong hospital stays by a mean of 11 days[4][4] and cost the US economy
No takes yet. Share an insight, caveat, or question.
P.J. Devereaux (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: